[go: up one dir, main page]

TWI424861B - And a method for producing the regenerated film and the method for producing the regenerated film - Google Patents

And a method for producing the regenerated film and the method for producing the regenerated film Download PDF

Info

Publication number
TWI424861B
TWI424861B TW99125493A TW99125493A TWI424861B TW I424861 B TWI424861 B TW I424861B TW 99125493 A TW99125493 A TW 99125493A TW 99125493 A TW99125493 A TW 99125493A TW I424861 B TWI424861 B TW I424861B
Authority
TW
Taiwan
Prior art keywords
film
regenerated film
regenerated
pore
layer
Prior art date
Application number
TW99125493A
Other languages
Chinese (zh)
Other versions
TW201204418A (en
Inventor
Chen Jung Chang
Wen Tao Huang
Hsien Te Chen
Yueh Hsiu Yen
Original Assignee
Univ Central Taiwan Sci & Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Central Taiwan Sci & Tech filed Critical Univ Central Taiwan Sci & Tech
Priority to TW99125493A priority Critical patent/TWI424861B/en
Publication of TW201204418A publication Critical patent/TW201204418A/en
Application granted granted Critical
Publication of TWI424861B publication Critical patent/TWI424861B/en

Links

Landscapes

  • Materials For Medical Uses (AREA)

Description

應用於組織修復工程之再生膜及該再生膜的製備方法Regeneration film applied to tissue repair engineering and preparation method of the same

本發明與醫學之組織修復及再生領域有關,更詳而言之,係一種輔助及促進組織修復工程的膜狀物質,該膜狀物質具有流入及流出速率不對等之通透性,以及生物組織降解性,並可為藥物載體。本案涉及該膜狀物質的構造以及研製該膜狀物質的方法。The present invention relates to the field of tissue repair and regeneration of medicine, and more specifically, to a membrane-like substance which assists and promotes tissue repair engineering, the membrane-like substance has permeability of unequal inflow and outflow rates, and biological tissue Degradability, and can be a drug carrier. The present invention relates to the construction of the film-like substance and a method of developing the film-like substance.

組織修復係指局部組織或細胞因某種致病因素而遭受損傷或死亡後,由鄰近健康細胞的再生來修補,以恢復組織完整性的過程。修復過程的快慢及完整與否受許多因素的影響,這些因素除受損傷的組織類型外,還有致損傷因子、營養、血液供應、感染、組織缺損率等。組織再生則是指組織損傷後細胞分裂增生以完成修復的過程。除了自體發生的修復及再生過程之外,在創傷處利用輔物可以促進組織修復再生工程。Tissue repair refers to the process by which local tissues or cells are damaged or killed by certain pathogenic factors and repaired by regeneration of adjacent healthy cells to restore tissue integrity. The speed and completeness of the repair process are affected by many factors, including the damage type, nutrition, blood supply, infection, and tissue defect rate. Tissue regeneration refers to the process of cell division and proliferation after tissue damage to complete the repair. In addition to autologous repair and regeneration processes, the use of excipients at the wound site can promote tissue repair regeneration.

再生膜即為上述輔物之一種,將再生膜置於組織損傷處的表面,在其所覆蓋的區域中隔離不必要的細胞、纖維組織或上皮組織等侵入損傷面,同時可以讓血液、養份或藥物通過,並且排除組織修復及再生工程中所產生的廢物。再生膜的放置可製造並組構一組織修織修復再生的空間。The regenerative membrane is one of the above-mentioned auxiliary materials, and the regenerative membrane is placed on the surface of the tissue damage, and the invading damage surface such as unnecessary cells, fibrous tissue or epithelial tissue is isolated in the area covered thereby, and the blood can be maintained. The drug or drug is passed and the waste generated in the tissue repair and regeneration project is excluded. The placement of the regenerative membrane allows for the fabrication and organization of a tissue-textured repair regenerative space.

以骨之修復再生為例,再生膜概可分為不可吸收再生膜以及可吸收再生膜兩種。Taking the repair of bone as an example, the regenerated film can be divided into two types: non-absorbable regenerative film and absorbable regenerative film.

不可吸收再者膜常見的材料有Gore-TEXR、MilliporeR、BiobarrierR。它含有特殊的生化材料如e-polytetrafluoroethylene(e-PTFE),對牙科種植體的骨整合有明顯的幫助。除了抑制上皮及纖維細胞侵入受損處之外, 還能促進骨細胞生長,它還具備以下特性:細胞隔絕性(cell occlusivity)、空間創造性(space making)、組織整合性(tissue integration)、生物相容性(biocompatability)、良好的穩定性及可靠性。Common materials that are not absorbable are Gore-TEXR, MilliporeR, BiobarrierR. It contains special biochemical materials such as e-polytetrafluoroethylene (e-PTFE), which is a significant aid to the osseointegration of dental implants. In addition to inhibiting the invasion of epithelial and fibroblasts, It also promotes bone cell growth. It also has the following properties: cell occlusivity, space making, tissue integration, biocompatibility, good stability and reliability. Sex.

可吸收再生膜是從1990年開始發展,依材料組成之不同而可分為三大類。Absorbable regenerative membranes have been developed since 1990 and can be divided into three categories depending on the composition of the materials.

第一類為膠原蛋白(collagen)再生膜:經交叉連結處理可以改善它的物理性質和吸收時間,使它的吸收時間可延至8週以上,有助於骨再生應用,如Bio-GageR、Bio-MendR、AtrisorbR。The first type is collagen regeneration membrane: cross-linking treatment can improve its physical properties and absorption time, so that its absorption time can be extended to more than 8 weeks, which is beneficial to bone regeneration applications, such as Bio-GageR, Bio. -MendR, AtrisorbR.

第二類為聚合體(Polymer)再生膜:主要是由多乳酸和多甘醇酸所聚合而成,functional integrity時間延至8-10週,完全吸收需6-7個月,提供完整之組織隔絕。如Resolut XtR。The second type is the polymer regeneration film: mainly composed of polylactic acid and polyglycolic acid. The functional integrity time is extended to 8-10 weeks, and the complete absorption takes 6-7 months to provide complete tissue isolation. . Such as Resolut XtR.

第三類為前面二種材料外之其它再生膜總稱。The third category is the general term for other recycled membranes other than the first two materials.

目前用於組織損傷再生之再生膜有很多種,過去使用大多是人工合成材料,材料的優點為操作性佳,具有良好的生物相容性,以骨損傷為例,可併用含鈦材料或其它充填材料以獲得更穩定及更大的骨生長空間。此類再生膜,由於是不可吸收之材質,所以手術後約4至8週須再次手術將再生膜取出,如有暴露易造成感染而影響骨生長。現在再生膜已發展出許多種可吸收材質,置入後可慢慢被人體吸收,優點是可免除第二次手術。有許多文獻報告指出可吸收與不可吸收再生膜在臨床上的效果是大同小異的。At present, there are many kinds of regenerative membranes used for tissue damage regeneration. Most of the materials used in the past are synthetic materials. The advantages of the materials are good operability and good biocompatibility. For example, bone damage can be combined with titanium-containing materials or other materials. Fill the material to achieve a more stable and larger space for bone growth. Since such a regenerative membrane is a non-absorbable material, it is necessary to re-examine the regenerated membrane about 4 to 8 weeks after the operation, and if it is exposed, it may cause infection and affect bone growth. Nowadays, the regenerative membrane has developed many kinds of absorbable materials, which can be slowly absorbed by the human body after being placed. The advantage is that the second operation can be dispensed with. There are many reports that the clinical effects of absorbable and non-absorbable regenerative membranes are much the same.

上述可吸收型或不可吸收型再生膜均具有相當的孔隙率而維持通透性,通透性是由膜兩側的流出速率與流入速率決定,而流出速率與流入速 率幾乎對等,吾等稱其為對等通透性。然而對等通透性將會淡化再生膜對組織修復及再生的促成。因為,組織損傷之初期、中期及末期都有不同的反應變化,在初期,損傷處充滿血腫、血塊、甚至有發炎反應,產生的大量壞死細胞和組織液應加速向膜外擴散排除,才能降低發炎反應;在中期和後期,生長因子開始長成並發揮作用,此時的再生膜必需阻止上皮細胞與結締組織透過膜而入侵受傷處。當再生膜為對等通透性時,將造成向膜外擴散排除速率與向膜內滲透侵入速率對等,而造成不利物質的排除速率降低及無法有效控制不利物質入侵的結果。The above-mentioned absorbable or non-absorbable regenerative membranes have comparable porosity and maintain permeability, and the permeability is determined by the outflow rate and the inflow rate on both sides of the membrane, and the outflow rate and the inflow rate. The rate is almost equal, we call it peer-to-peer. However, peer-to-peer permeability will dilute the contribution of the regenerative membrane to tissue repair and regeneration. Because the initial, middle and end of tissue damage have different reaction changes, in the initial stage, the lesion is full of hematoma, blood clots and even inflammatory reactions, and a large number of necrotic cells and tissue fluids should be accelerated to the extramembranous diffusion to eliminate inflammation. In the middle and late stages, growth factors begin to grow and function. At this time, the regenerative membrane must prevent epithelial cells and connective tissue from permeating through the membrane and invading the injured area. When the regenerated membrane is equivalent to permeation, it will result in an equal rate of diffusion to the membrane and a rate of penetration into the membrane, resulting in a decrease in the rate of elimination of the unfavorable substance and inability to effectively control the invasion of the unfavorable substance.

由此可知,再生膜的流入與流出通透率(inflow and outflow permeability)對於組織修復及再生有重要的影響性。但以往對再生膜的研究,大多只聚焦於材料之選用及組合,並未對流入與流出通透率進行研究及發展。From this, it can be seen that the inflow and outflow permeability of the regenerated membrane has an important influence on tissue repair and regeneration. However, most of the research on recycled membranes has focused on the selection and combination of materials, and has not studied and developed the inflow and outflow permeability.

本案之目的係在提供一種應用於組織修復工程之再生膜,該再生膜具有流入與流出通透率(inflow and outflow permeability)不對稱之特性,為一高單向通透率之再生膜,所謂的高單向通透率可以是高內流或高外流,需藉由損傷部位之需求,而決定對損傷區域採高外流或高內流應用模式。在高外流的應用模式下,該再生模可將組織損傷處所產生的大量壞死細胞和組織液等廢物加速排除,降低發炎反應,並隔絕上皮細胞、結締組織等不利物質侵入損傷處,從而輔助及促進組織修復工程之進行。該再生膜可為一藥物載體,在高內流的應用模式下,將對組織修復再生之有利物質或藥物導入受損組織,從而加速組織修復再生功能之進行。The purpose of the present invention is to provide a regenerative membrane for use in tissue repair engineering, which has the characteristics of asymmetry of inflow and outflow permeability, and is a regenerative membrane with a high unidirectional permeability. The high unidirectional permeability can be high inflow or high outflow, and it is determined by the demand of the damaged part to determine the application mode of the high outflow or high inflow to the damaged area. In the application mode of high outflow, the regenerative model can accelerate the elimination of a large amount of waste cells such as necrotic cells and tissue fluid generated in the tissue damage, reduce the inflammatory reaction, and insulate the invasive lesions such as epithelial cells and connective tissue, thereby assisting and promoting Organize the restoration project. The regenerative membrane can be a drug carrier, and in a high inflow application mode, the beneficial substance or drug for repairing and regenerating tissue is introduced into the damaged tissue, thereby accelerating the tissue repair regeneration function.

本案之目的係在提供一種應用於組織修復工程之再生膜,該再生膜具有生物可降解性,於組織缺陷修復手術中被植入損傷部位後即無需第二次手術取出。The purpose of the present invention is to provide a regenerative membrane for use in tissue repair engineering which is biodegradable and which does not require a second surgical removal after being implanted into the injury site during tissue defect repair surgery.

本案之目的係在提供一種製造上述再生膜之方法,該方法所產製的再生膜具有大孔隙層和小孔隙層,該大孔隙層具有大孔隙表面,該小孔隙層具有小孔隙表面。本發明之方法可進一步控制該大孔隙層和小孔隙層的孔隙尺寸及數量的比例差異,差異越大,則通透率之不對稱度越高,高單向通透率亦愈明顯。The object of the present invention is to provide a method for producing the above-described regenerated film which has a large pore layer and a small pore layer, the large pore layer having a large pore surface having a small pore surface. The method of the invention can further control the difference in the ratio of the pore size and the number of the large pore layer and the small pore layer. The greater the difference, the higher the asymmetry of the permeability and the higher the high unidirectional permeability.

本案之目的係在提供一種製造上述再生膜之方法,該方法可進一步控制大孔隙層和小孔隙層的比例差異,進而調整高單向通透率。The purpose of the present invention is to provide a method for producing the above-described regenerated film which can further control the difference in the ratio of the macroporous layer to the small pore layer, thereby adjusting the high unidirectional permeability.

本案之目的係在提供一種製造上述再生膜之方法,該方法所產製之再生膜不具有習知的皮層效應,因此可保持預期的高單向通透率。The object of the present invention is to provide a method for producing the above-mentioned regenerated film which does not have a conventional cortical effect and thus maintains a desired high unidirectional permeability.

本案之不對稱再生膜之皮層效應缺點藉由親水性凝膠層製程而改善。The disadvantage of the cortical effect of the asymmetric regenerated film of the present invention is improved by the hydrophilic gel layer process.

一種應用於組織修復工程之再生膜,該再生膜包含:鄰接結合的一第一孔隙層和一第二孔隙層;該第一孔隙層和第二孔隙層分佈有多數個與外部環境相連通的孔隙,且該第一孔隙層的孔隙尺寸大於該第二孔隙層的孔隙。A regenerative film applied to a tissue repairing process, the regenerative film comprising: a first void layer and a second pore layer adjacent to each other; the first pore layer and the second pore layer are distributed with a plurality of connected to the external environment a pore, and a pore size of the first pore layer is larger than a pore of the second pore layer.

一種應用於組織修復工程之再生膜之製備方法,包括:步驟一,將高分子材料與第一溶劑以預定比例混合配製成高分子溶液;步驟二,將該高分子溶液附著於一模具表面而形成一再生膜半成品;步驟三,以第二溶劑對該再生膜半成品進行隙孔生成加工,於該再生膜半成品之膜壁上形成上述之孔隙。A method for preparing a regeneration film applied to a tissue repairing process, comprising: step 1: mixing a polymer material with a first solvent in a predetermined ratio to form a polymer solution; and step 2, attaching the polymer solution to a mold surface And forming a regenerated film semi-finished product; in step 3, the regenerated film semi-finished product is subjected to a pore-forming process by a second solvent, and the above-mentioned pores are formed on the film wall of the regenerated film semi-finished product.

為便於說明本案於上述發明內容一欄中所表示的中心思想,茲以具體實施例表達。實施例中各種不同物件係按適於說明之比例、尺寸、變形量或位移量而描繪,而非按實際元件的比例予以繪製,合先敘明。且以下的說明中,類似的元件是以相同的編號來表示。For the convenience of the description, the central idea expressed in the column of the above summary of the present invention is expressed by a specific embodiment. Various items in the embodiments are depicted in terms of ratios, dimensions, amounts of deformation, or displacements that are suitable for illustration, and are not drawn to the proportions of actual elements, as set forth above. In the following description, like elements are denoted by the same reference numerals.

如第一圖,係以工業繪圖方法描繪本案再生膜的剖面,本發明之再生膜10是以具有生物降解性之高分子聚合物所製成,該再生膜10之其中一側為一第一孔隙層11,該再生膜10的另一側為一第二孔隙層12,該第一孔隙層11和第二孔隙層12均具有與外部環境連通的多數孔隙111,121,且該第一孔隙層11的孔隙111尺寸大於該第二孔隙層12的孔隙121。該再生膜10其中一側之表面為第一表面13,該再生膜10之另一側之表面為第二表面14,該第一表面13具有該第一孔隙層11之孔隙111,該第二表面14具有該第二孔隙層12之孔隙121,該第一表面13的孔隙111尺寸大於該第二表面14的孔隙121尺寸。如第二圖,係以工業繪圖方法分別描繪該第一表面13和第二表面14的表面態様。如第三圖,係以工業繪圖方法描繪本案再生膜之不對稱通透率。基於孔隙尺寸之差異,該再生膜10從第一孔隙層11和第一表面13向第二孔隙層12和第二表面14的通透率高於從第二孔隙層12和第二表面14向第一孔隙層11和第一表面13的通透率。換言之,該再生膜10之膜兩側的通透率是不對稱的。且上述孔隙的尺寸和數量的比例差異愈大,該通透率之不對稱度越高,高單向通透率亦愈明顯。在第三圖之圖例中,描述了從第一孔隙層11向第二孔隙層12流通的高單向通透率。As shown in the first figure, the cross section of the regenerated film of the present invention is depicted by an industrial drawing method. The regenerated film 10 of the present invention is made of a biodegradable polymer, and one side of the regenerated film 10 is a first The pore layer 11, the other side of the regeneration film 10 is a second pore layer 12, each of the first pore layer 11 and the second pore layer 12 has a plurality of pores 111, 121 communicating with the external environment, and the first pore layer 11 The pores 111 are larger in size than the pores 121 of the second pore layer 12. The surface of one side of the regenerated film 10 is a first surface 13 , and the surface of the other side of the regenerated film 10 is a second surface 14 having a hole 111 of the first pore layer 11 , the second The surface 14 has an aperture 121 of the second aperture layer 12, the aperture 111 of the first surface 13 being sized larger than the aperture 121 of the second surface 14. As shown in the second figure, the surface states of the first surface 13 and the second surface 14 are respectively depicted by an industrial drawing method. As shown in the third figure, the asymmetric permeability of the regenerated film of the present invention is depicted by an industrial drawing method. The permeability of the regenerated film 10 from the first pore layer 11 and the first surface 13 to the second pore layer 12 and the second surface 14 is higher than that from the second pore layer 12 and the second surface 14 based on the difference in pore size. The permeability of the first pore layer 11 and the first surface 13. In other words, the permeability of both sides of the film of the regenerated film 10 is asymmetrical. Moreover, the greater the difference in the ratio of the size and the number of the above pores, the higher the asymmetry of the permeability and the higher the high unidirectional permeability. In the legend of the third figure, a high unidirectional permeability from the first pore layer 11 to the second pore layer 12 is described.

基於組織降解性之需求,本案再生膜採用高分子材料製做,做為本發明高分子材料的例子,包含但不限於聚乳酸甘醇酸共聚物(poly(DL-lactci acid-co-glycolic acid),以下簡稱PLGA)、聚己內酯(poly ε-caprolactone,PCL)、聚乳酸(polylactide acid,PLA)與幾丁聚醣(chitosan)等。Based on the demand for tissue degradability, the regenerated film of the present invention is made of a polymer material, and is an example of the polymer material of the present invention, including but not limited to polylactic acid glycol copolymer (poly(DL-lactci acid-co-glycolic acid). ), hereinafter referred to as PLGA), poly ε-caprolactone (PCL), polylactide acid (PLA), chitosan, and the like.

以上述材料製做再生膜的方法,主要包括以下步驟:步驟一,將高分子材料與第一溶劑以預定比例混合配製成高分子溶液;步驟二,將該高分子溶液附著於一模具表面而形成一再生膜半成品;步驟三,以第二溶劑對該再生膜半成品進行隙孔生成加工,於該再生膜半成品之兩側分別形成一上述的第一孔隙層和第二孔隙層;步驟四,清洗、乾燥、脫膜,完成一具有不對稱孔隙之再生膜。The method for preparing a regenerated film by using the above materials mainly comprises the following steps: Step 1: mixing a polymer material with a first solvent in a predetermined ratio to prepare a polymer solution; and Step 2, attaching the polymer solution to a mold surface Forming a regenerated film semi-finished product; in step 3, performing a slit hole forming process on the regenerated film semi-finished product with a second solvent, and forming a first pore layer and a second pore layer on the two sides of the regenerated film semi-finished product; , cleaning, drying, stripping, and completing a regenerated film with asymmetric pores.

可應用於本發明中的第一溶劑,在此並沒有特別的限制,只要是可使高分子材料得以溶解於其中的即可。若使用的高分子材料為聚乳酸甘醇酸共聚物、聚己內酯、聚乳酸時,作為第一溶劑的例子包含但不限於1,4-二氧陸圜(1,4-dioxane)、氯仿(chloroform)與六氟異丙醇(hexafluoroisopropanol,HFIP)等。若使用的高分子材料為幾丁聚醣時,作為第一溶劑的例子包含醋酸水溶液等,但並不僅限於此。高分子溶液的濃度於本發明並沒有特別的限制,但為使其易於操作及成膜,較佳為10%(w/w)。The first solvent which can be used in the present invention is not particularly limited as long as it can dissolve the polymer material therein. When the polymer material to be used is a polylactic acid glycolic acid copolymer, polycaprolactone, or polylactic acid, examples of the first solvent include, but are not limited to, 1,4-dioxane, Chloroform (chloroform) and hexafluoroisopropanol (HFIP). When the polymer material to be used is chitosan, an example of the first solvent includes an aqueous acetic acid solution or the like, but is not limited thereto. The concentration of the polymer solution is not particularly limited in the present invention, but is preferably 10% (w/w) in order to make it easy to handle and form a film.

步驟二中所採用的模具以平板模具為較佳,模具的形狀可依據所需要的膜形而加以備製。平板模具的材料於本發明中並沒有特別的限制,只要是不會與該高分子材料及/或第一溶劑起反應,且可便於脫膜者,均可被應用於本發明中。可舉出的例子包含但不限於金屬、玻璃、石英等。The mold used in the second step is preferably a flat mold, and the shape of the mold can be prepared according to the desired shape of the film. The material of the flat plate mold is not particularly limited in the present invention, and any one which does not react with the polymer material and/or the first solvent and which can facilitate the release of the film can be applied to the present invention. Examples which may be mentioned include, but are not limited to, metals, glass, quartz, and the like.

前述步驟二中使高分子溶液黏附於模具表面的方法,在本發明中並沒有特別的限制,只要是任何習知可將高分子溶液黏附於模具表面者,皆可被應用於本發明中,包含但不限於習知的浸漬-鑄膜、澆淋附著...等方法。The method of adhering the polymer solution to the surface of the mold in the foregoing step 2 is not particularly limited in the present invention, and any conventional polymer solution can be applied to the surface of the mold, and can be applied to the present invention. Including, but not limited to, conventional methods such as dipping-casting, pouring, and the like.

前述再生膜半成品膜壁外層的孔隙大小可藉由步驟三中的第二溶劑的極性大小來調節,當第二溶劑的濃度愈低(極性愈高),孔隙的尺寸也就愈大;反之,當第二溶劑的濃度愈高(極性愈小),孔隙的尺寸也就愈小。例如,當以乙醇水溶液為第二溶劑時,乙醇水溶液的濃度較佳為10~60%(v/v),更佳為20~40%(v/v)。膜壁外層與膜壁內層的孔隙大小差異越大,再生膜通透率之不對稱度越高,亦即物質通透進出膜壁的不對稱單側高流率也愈明顯。The pore size of the outer layer of the regenerated membrane semi-finished membrane wall can be adjusted by the polarity of the second solvent in the third step. When the concentration of the second solvent is lower (the higher the polarity), the pore size is larger; The higher the concentration of the second solvent (the smaller the polarity), the smaller the pore size. For example, when the aqueous ethanol solution is used as the second solvent, the concentration of the aqueous ethanol solution is preferably from 10 to 60% (v/v), more preferably from 20 to 40% (v/v). The greater the difference in pore size between the outer layer of the membrane wall and the inner layer of the membrane wall, the higher the asymmetry of the permeability of the regeneration membrane, that is, the asymmetric unilateral high flow rate of the material permeating into and out of the membrane wall.

以往所習知之浸漬-鑄膜法會於再生膜之表面形成皮層效應,以本案前述之再生膜10為例,說明該皮層效應的現象。理想的再生膜10應為前述實施例所描寫的,其第一孔隙層11和第一表面13的孔隙尺寸大於第二孔隙層12和第二表面14。然而,當皮層效應產生時,第一表面13的孔隙尺寸竟然小於第二表面14,這對於原本預期的高單向通透率產生嚴重影響。為解決此一問題,本發明於執行步驟二之前,先在模具的表面預先塗佈一層親水性凝膠層,該親水性凝膠層為不溶或難溶於第一溶劑的物質,包含但不限於生物性聚乙烯醇(Polyvinyl Alcohol,PVA)、明膠或F127凝膠等。此親水性凝膠可在上述步驟三再生膜半成品浸置於第二溶劑開始成膜時,阻斷第二溶劑侵入高分子材料與平板膜具之間,水凝膠的親水性高於高分子溶液,故該親水性凝膠層會吸取大部分之第二溶劑,可讓該再生膜的內側接觸最少之第二溶劑,從而維持第一孔隙層11和第一表面13的孔隙尺寸大於第二孔隙層12和第二表面14的理想狀況。The conventional immersion-casting method forms a cortical effect on the surface of the regenerated film, and the regenerated film 10 of the present invention is taken as an example to explain the phenomenon of the cortex effect. The ideal regenerated film 10 should be as described in the foregoing embodiments, with the first pore layer 11 and the first surface 13 having a larger pore size than the second pore layer 12 and the second surface 14. However, when the cortical effect is produced, the pore size of the first surface 13 is actually smaller than that of the second surface 14, which has a severe effect on the originally expected high unidirectional permeability. In order to solve the problem, the present invention pre-coats a hydrophilic gel layer on the surface of the mold before the step 2 is performed. The hydrophilic gel layer is a substance that is insoluble or poorly soluble in the first solvent, including but not Limited to bio-polyvinyl alcohol (PVA), gelatin or F127 gel. The hydrophilic gel can block the second solvent from invading between the polymer material and the flat membrane when the regenerated membrane semi-finished product is immersed in the second solvent to form a film, and the hydrophilicity of the hydrogel is higher than that of the polymer. a solution, so that the hydrophilic gel layer absorbs most of the second solvent, allowing the inner side of the regenerated film to contact the second solvent with a minimum, thereby maintaining the pore size of the first pore layer 11 and the first surface 13 larger than the second The ideal condition of the void layer 12 and the second surface 14.

以下實驗即利用PLGA高分子材料溶於1-4dioxan(第一溶劑),並將其黏附於玻璃材質之平板模具上後利用95%與40%乙醇(第二溶劑)分別進行浸漬-沉澱法反應。The following experiment uses PLGA polymer material dissolved in 1-4 dioxan (first solvent), and adheres it to a glass plate mold, and then uses 95% and 40% ethanol (second solvent) to perform the impregnation-precipitation reaction. .

請參照第四圖和第五圖,為利用95%乙醇浸漬-沉澱法後再生膜之掃描式電子顯微鏡圖(SEM),其中第四圖為再生膜之橫切面,第五圖為該再生膜的上表面及下表面。第六圖及第七圖則為利用40%乙醇浸漬-沉澱法後再生膜之電子顯微鏡圖(SEM),其中第六圖為再生膜之橫切面,第七圖為膜之第一表面和第二表面。以95%乙醇浸漬-沉澱法之再生膜做為控制組,在電子顯微鏡的觀察下,其橫切面表現出對稱的小孔隙結構層30,且再生膜的上表面及下表面皆為小孔隙表面層31,32。而第六圖及第七圖則為本案之再生膜10,電子顯微鏡圖(SEM)顯示其橫切面具有第一孔隙層11和第二孔隙層12,該第一孔隙層11和第二孔隙層12均具有與外部環境連通的多數孔隙111,121,且該第一孔隙層11的孔隙111尺寸大於該第二孔隙層12的孔隙121。該第一孔隙層11具有一第一表面13,該第二孔隙層12具有一第二表面14,該第一表面13的孔隙尺寸大於該第二表面14的孔隙尺寸。從SEM結果顯示,上述習知之沈漬-沈澱法所造成的皮層效應,在本發明中並沒有發生。Please refer to the fourth and fifth figures for the scanning electron micrograph (SEM) of the regenerated film after the 95% ethanol immersion-precipitation method, wherein the fourth picture is the cross section of the regenerated film, and the fifth picture is the regenerated film. Upper and lower surfaces. The sixth and seventh figures are electron micrographs (SEM) of the regenerated film after 40% ethanol impregnation-precipitation method, wherein the sixth picture is the cross section of the regenerated film, and the seventh picture is the first surface of the film and the first Two surfaces. The regenerated film of the 95% ethanol impregnation-precipitation method was used as a control group. Under the observation of the electron microscope, the cross section showed a symmetric small pore structure layer 30, and both the upper surface and the lower surface of the regenerated film were small pore surfaces. Layers 31, 32. The sixth and seventh figures are the regenerated film 10 of the present invention, and the electron micrograph (SEM) shows that the cross section has the first pore layer 11 and the second pore layer 12, and the first pore layer 11 and the second pore layer Each of the 12 has a plurality of pores 111, 121 in communication with the external environment, and the pores 111 of the first pore layer 11 are larger in size than the pores 121 of the second pore layer 12. The first aperture layer 11 has a first surface 13 and the second aperture layer 12 has a second surface 14 having a pore size greater than a pore size of the second surface 14. From the SEM results, it was revealed that the cortical effect caused by the above-described conventional stain-precipitation method did not occur in the present invention.

本發明之再生膜具有不對稱通透率,可由以下實驗證明。The regenerated film of the present invention has an asymmetric permeability and can be proved by the following experiment.

本通透率實驗為利用10%葡萄糖溶液,分別置入四個玻璃管中,其中第一支玻璃管之端口被本案之再生膜(對照組40%乙醇浸漬)以第一表面黏著封口,第二支玻璃管之端口被本案之再生膜(對照組40%乙醇浸漬)以第二表面黏著封口,第三支及第四支玻璃管分別被控制組(95%乙醇浸漬)再生 膜的上表面及下表面黏著封口。接著,將此些裝有溶液之玻璃管,分別浸入5ml裝載於瓶子內的磷酸鹽緩衝溶液中。之後,於1、2及3天後,自瓶子內的磷酸鹽緩衝溶液中取出20μl,分別分析其葡萄糖濃度。在此,葡萄糖濃度測定係藉由紫外光分光光度計(Hitachi Co.,U-2000),於500nm的波長下進行測定。The permeability test was carried out by using 10% glucose solution and placed in four glass tubes respectively. The port of the first glass tube was sealed by the regeneration membrane of the present invention (40% ethanol in the control group), and the first surface was sealed. The ports of the two glass tubes were sealed by the regenerative membrane of the present case (40% ethanol in the control group), and the third and fourth glass tubes were respectively regenerated by the control group (95% ethanol impregnation). The upper surface and the lower surface of the film are adhered to the seal. Next, the glass tubes containing the solutions were each immersed in 5 ml of a phosphate buffer solution loaded in a bottle. Thereafter, after 1, 2, and 3 days, 20 μl was taken out from the phosphate buffer solution in the bottle, and the glucose concentration was separately analyzed. Here, the glucose concentration measurement was carried out by an ultraviolet spectrophotometer (Hitachi Co., U-2000) at a wavelength of 500 nm.

請參閱第八圖,為葡萄糖通透膜壁的雙向通透率之結果分析圖。從第八圖中可以看出,對照組(40%再生膜)顯示顯著的高單向通透率(<0.001),其第一孔隙層11(大孔隙層)往第二孔隙層12(小孔隙層)的通透率大於第二孔隙層12(小孔隙層)往第一孔隙層11(大孔隙層)的通透率。然而控制組因為皆為小孔隙層31,32,同樣以上述方式分別觀察雙側之通透率,其結果顯示該膜具低的雙側流通率。Please refer to the eighth figure for the analysis of the results of the two-way permeability of the glucose permeable membrane wall. As can be seen from the eighth figure, the control group (40% regenerated film) showed a remarkable high unidirectional permeability (<0.001), and the first pore layer 11 (large pore layer) to the second pore layer 12 (small) The permeability of the pore layer is greater than the permeability of the second pore layer 12 (small pore layer) to the first pore layer 11 (large pore layer). However, since the control group was all of the small pore layers 31, 32, the permeability of both sides was also observed in the above manner, and the results showed that the film had a low bilateral flow rate.

本案更進一步將其進行動物實驗,請參照附件一,於無菌操作下將八周大白鼠頭蓋骨上以外口手術磨棒製造二個直徑5mm深度0.5mm之圓形骨損傷,並在其上面覆蓋本案之再生膜,覆蓋方式有兩種,第一種是以本案再生膜的第一表面13覆蓋於骨損傷處40表面(如第九圖);第二種是以本案再生膜的第二表面14覆蓋於骨損傷處40表面(如第十圖)。第一種覆蓋方式構成骨損傷處40高外流低內流通透率(High outflow and low inflow permeability,HOLI)之環境,第二種覆蓋方式構成高內流低外流通透率(High inflow and low outflow permeability,HILO)之環境。另外並與低外內流通透率組(low permeability,LP)、無再生膜控制組(control)進行比較。In this case, the animal experiment is further carried out. Please refer to Annex I. Under the aseptic operation, two round bone wounds with a diameter of 5 mm and a depth of 0.5 mm can be made from the outer grinding head of the eight-week white rat head bone cover, and the case is covered on the case. There are two ways of regenerating the film. The first type is that the first surface 13 of the regenerated film of the present invention covers the surface of the bone damage portion 40 (as shown in FIG. 9); the second type is the second surface 14 of the regenerated film of the present invention. Covers the surface of the bone lesion 40 (as in the tenth image). The first type of coverage constitutes an environment of high outflow and low inflow permeability (HOLI), and the second type of coverage constitutes high inflow and low outflow (High inflow and low outflow). Permeability, HILO) environment. In addition, it is compared with a low external permeability group (low permeability, LP) and a non-regeneration membrane control group.

於4、8、12周將其頭蓋骨取下進行X光攝影,定量其骨損傷修復百分比(bone defect regeneration percentage,BDRp),其結果請參照第十一 圖,以此實驗結果可觀察出在各時間點上尤其是8與12周之結果,利用HOLI組皆較他組之結果復原速度快。由是可證,在高外流的環境下,該再生模可將組織損傷處所產生的大量壞死細胞和組織液等廢物加速排除,降低發炎反應,並隔絕上皮細胞等結締組織等不利物質侵入損傷處,從而輔助及促進組織修復工程之進行。At 4, 8, and 12 weeks, the skull was removed for X-ray photography, and the bone defect regeneration percentage (BDRp) was quantified. For the results, please refer to the eleventh. Fig., the results of this experiment can be observed at various time points, especially 8 and 12 weeks. The results of using HOLI group are faster than those of other groups. It can be proved that in the environment of high outflow, the regenerative mold can accelerate the elimination of a large amount of waste such as necrotic cells and tissue fluid generated by the tissue damage, reduce the inflammatory reaction, and insulate the harmful substances such as connective tissue such as epithelial cells from invading the damage. Thereby assisting and promoting the organization of the restoration project.

實驗鼠另外更進行電腦斷層掃描並利用影像重組觀察骨損傷之修復情形,其結果請參照附件二,利用HOLI組的骨損傷於第四周與十二周的電腦斷層重組影像可看出中幾已修復完成(白色箭頭處),然而他組再生膜之修復效率則為較差。In addition, the rats were further scanned by computer tomography and reconstructed by bone reconstruction. The results are shown in Annex II. The bone damage of the HOLI group can be seen in the computerized tomographic images of the fourth and the 12th week. The repair has been completed (white arrow), but the repair efficiency of his group of recycled membranes is poor.

並於X光攝影實驗完後,利用H&E染色法進行組織切片染色,其第八周之結果顯示於附件三,附件三為本案HOLI於第八周之切片結果,附件四為本案之LP組。NB為再生骨,OB為舊骨,黑色箭頭為骨小島,而新生骨中顏色較深為尚未成熟之新生骨,結果顯示本創作之不對稱骨再生膜對於骨損傷之新骨生成於前期生長較快,骨小島分布較密集,代表新骨之成熟度較高,由附件四可看出,其骨小島分布較少,且顏色較深,意即代表此組於第八周仍正在進行骨化作用,其為表面膠原蛋白聚集,新生骨成熟度較差。After the X-ray photography experiment, the H&E staining method was used for tissue section staining. The results of the eighth week are shown in Annex III. The third part is the slice result of HOLI in the eighth week, and the fourth group is the LP group of the case. NB is the regenerative bone, OB is the old bone, the black arrow is the bone island, and the new bone is darker in color than the immature new bone. The result shows that the asymmetric bone regeneration membrane of this creation is for the new bone formation of bone damage in the early growth. Faster, the distribution of bone islands is more dense, which means that the maturity of new bones is higher. As can be seen from Annex IV, the distribution of bone islands is less and the color is darker, which means that the group is still undergoing bone in the eighth week. Chemical action, which is the accumulation of surface collagen, and the maturity of new bone is poor.

綜上所陳,本案之不對稱再生膜具下列優點:再生膜使用之材料為生物相容性極高之高分子聚合物,具有生物可降解性,於組織缺陷修復手術中無需二次手術取出再生膜。In summary, the asymmetric regenerative membrane of the present invention has the following advantages: the material used for the regenerated membrane is a highly biocompatible polymer, which is biodegradable and does not require a second surgical removal during tissue defect repair surgery. Recycled film.

本案之再生膜具有不對稱之孔隙結構,即具大小孔隙層。該不對稱結構使再生膜具有不對稱之通透率。The regenerated film of the present invention has an asymmetric pore structure, that is, a pore layer having a size. The asymmetric structure provides a reproducible membrane with an asymmetric permeability.

本案之再生膜不對稱通透率可在製造過程中藉由溶劑的濃度而調整。The asymmetric membrane permeability of the regenerated membrane of the present invention can be adjusted by the concentration of the solvent during the manufacturing process.

本案之不對稱再生膜之皮層效應缺點藉由親水性凝膠層製程而改善。The disadvantage of the cortical effect of the asymmetric regenerated film of the present invention is improved by the hydrophilic gel layer process.

本案之不對稱再生膜具有高單向通透率,可在組織損傷處形成高外流低內流通透率(High outflow and low inflow permeability,HOLI)之環境,可大量排放出損傷造成的發炎代謝物,並阻隔有效上皮細胞侵入缺陷部影響生長。The asymmetric regeneration membrane of the present invention has a high unidirectional permeability, and can form an environment of high outflow and low inflow permeability (HOLI) at the tissue damage, and can discharge a large amount of inflammatory metabolites caused by damage. And block the effective epithelial cells from invading the defect to affect growth.

本案之不對稱再生膜具有高單向通透率,可對組織損傷處構成高外流低內流通透率(High outflow and low inflow permeability,HOLI)之環境,或高內流低外流通透率(High inflow and low outflow permeability,HILO)之環境。該單向流通率需藉由損傷部位之需求而選擇高外流環境或高內流環境。The asymmetric regeneration membrane of the present invention has a high unidirectional permeability, which can constitute a high outflow and low inflow permeability (HOLI) environment for tissue damage, or a high internal flow and low external flow permeability ( High inflow and low outflow permeability, HILO). The one-way flow rate needs to select a high outflow environment or a high inflow environment by the demand of the damaged part.

本案再生膜可為一藥物載體,如同本創作所揭示之三鈣磷酸鹽外,更可利用物理、化學方法交聯各式生長因子例如:PDGF(platelet derived growth factor)、TGF-β(transforming growth factors)、VEGF(vascular endothelial growth factor)、EGF(epithelial growth factor)、IGF(insulin-like growth factor);以及幫助組織再生之胜肽例如RGD;或是用血小板含量豐富的血漿platelet-rich plasma(簡稱PRP)這種現今醫學界上最常使用之材料。再生膜為藥物載體時,其覆蓋於組織損傷處的方式應以形成高內流環境為佳。The regenerated film of the present invention may be a drug carrier. In addition to the tricalcium phosphate disclosed in the present invention, various growth factors such as PDGF (platelet derived growth factor) and TGF-β (transforming growth) may be cross-linked by physical or chemical methods. Factors), VEGF (vascular endothelial growth factor), EGF (epithelial growth factor), IGF (insulin-like growth factor); and peptides that help tissue regeneration such as RGD; or platelet-rich plasma with platelet content Referred to as PRP), the most commonly used material in the medical world today. When the regenerative membrane is a drug carrier, the manner of covering the tissue damage site should preferably form a high influent environment.

本案創作之再生膜應用於硬骨缺陷修復來說明該膜之優勢,但再生膜應用於人體組織之修復並非為僅只有硬骨缺陷修復,組織缺損時皆須大量排出發炎物質以及阻隔其餘組織侵入,故需單向高通透率之不對稱再生膜。The regenerated membrane created in this case is applied to the repair of hard bone defects to illustrate the advantages of the membrane. However, the application of the regenerative membrane to the repair of human tissue is not only the repair of hard bone defects, but also the large amount of inflammatory substances and the invasion of other tissues when the tissue is damaged. Asymmetric regenerative membrane with one-way high permeability.

雖然本案是以一個最佳實施例做說明,但精於此技藝者能在不脫離本 案精神與範疇下做各種不同形式的改變。以上所舉實施例僅用以說明本案而已,非用以限制本案之範圍。舉凡不違本案精神所從事的種種修改或變化,俱屬本案申請專利範圍。Although this case is illustrated by a preferred embodiment, it is true that those skilled in the art can Various forms of change are made in the spirit and scope of the case. The above embodiments are only used to illustrate the present case and are not intended to limit the scope of the present invention. All kinds of modifications or changes that are not in violation of the spirit of the case are the scope of patent application in this case.

10‧‧‧再生膜10‧‧‧Regeneration film

11‧‧‧第一孔隙層11‧‧‧First pore layer

111‧‧‧孔隙111‧‧‧ pores

12‧‧‧第二孔隙層12‧‧‧Second pore layer

121‧‧‧孔隙121‧‧‧ pores

13‧‧‧第一表面13‧‧‧ first surface

14‧‧‧第二表面14‧‧‧ second surface

30‧‧‧小孔隙結構層30‧‧‧Small pore structure

31‧‧‧小孔隙表面層31‧‧‧Small pore surface layer

32‧‧‧小孔隙表面層32‧‧‧Small pore surface layer

40‧‧‧骨損傷處40‧‧‧Bone injury

第一圖,係以工業繪圖方法描繪本案再生膜的剖面。In the first figure, the cross section of the regenerated film of the present invention is depicted by an industrial drawing method.

第二圖,係以工業繪圖方法描繪本案再生膜第一表面和第二表面的表面態樣。In the second figure, the surface features of the first surface and the second surface of the regenerated film of the present invention are depicted by an industrial drawing method.

第三圖,係以工業繪圖方法描繪本案再生膜之不對稱通透率。In the third figure, the asymmetric permeability of the regenerated film of the present invention is depicted by an industrial drawing method.

第四圖,為利用95%乙醇浸漬-沉澱法後再生膜之電子顯微鏡(SEM)橫切面圖。The fourth figure is an electron microscope (SEM) cross-sectional view of the regenerated film after the 95% ethanol impregnation-precipitation method.

第五圖,為第四圖之再生膜的上表面及下表面。The fifth figure is the upper surface and the lower surface of the regenerated film of the fourth figure.

第六圖,為利用40%乙醇浸漬-沉澱法後再生膜之電子顯微鏡(SEM)橫切面圖。Fig. 6 is an electron microscope (SEM) cross-sectional view of the regenerated film after immersion-precipitation using a 40% ethanol.

第七圖,為第六圖再生膜的第一表面和第二表面。In the seventh figure, the first surface and the second surface of the film are reproduced in the sixth figure.

第八圖,為葡萄糖通透膜壁的雙向通透率之結果分析圖。Figure 8 is a graph showing the results of the two-way permeability of the glucose permeable membrane wall.

第九圖,以本案再生膜的第一表面覆蓋於骨損傷處表面,形成高外流低內流通透率環境之示意圖。In the ninth figure, the first surface of the regenerated film of the present invention covers the surface of the bone damage surface, and a schematic diagram of a high outflow low internal flow permeability environment is formed.

第十圖,以本案再生膜的第二表面覆蓋於骨損傷處表面,形成高內流低外流通透率環境之示意圖。In the tenth figure, the second surface of the regenerated film of the present invention covers the surface of the bone damage surface, and forms a high internal flow and low external flow permeability environment.

第十一圖,以取下小白鼠的頭蓋體進行X光攝影,定量其骨損傷修復百分比(bone defect regeneration percentage,BDRp)之結果。In the eleventh figure, X-ray photography was performed by removing the head cover of the mouse, and the result of the bone defect regeneration percentage (BDRp) was quantified.

附件一,於無菌操作下將八周大白鼠頭蓋骨上以外口手術磨棒製造二個直 徑5mm深度0.5mm之圓形骨損傷,並在其上面覆蓋本案之再生膜。Attachment 1, under the aseptic operation, the eight-week white rat skull bones are made of two external straight surgical rods. The circular bone with a diameter of 5 mm and a depth of 0.5 mm is damaged and covered with the regenerated film of the present invention.

附件二,實驗鼠更進行電腦斷層掃描並利用影像重組觀察骨損傷之修復情形。In Annex II, the experimental rats were further scanned by computed tomography and reconstructed using image reconstruction to observe the repair of bone injury.

附件三,對高外流低內流通透率(High outflow and low inflow permeability,HOLI)環境之損傷組織進行H&E染色法進行組織切片染色之結果。Annex III, the results of tissue section staining by H&E staining of damaged tissue in high outflow and low inflow permeability (HOLI) environment.

附件四,對低外內流通透率組(low permeability,LP)環境之損傷組織進行H&E染色法進行組織切片染色之結果。Annex IV, the results of tissue section staining by H&E staining of damaged tissue in a low permeability (LP) environment.

10‧‧‧再生膜10‧‧‧Regeneration film

11‧‧‧第一孔隙層11‧‧‧First pore layer

111‧‧‧孔隙111‧‧‧ pores

12‧‧‧第二孔隙層12‧‧‧Second pore layer

121‧‧‧孔隙121‧‧‧ pores

13‧‧‧第一表面13‧‧‧ first surface

14‧‧‧第二表面14‧‧‧ second surface

Claims (10)

一種應用於組織修復工程之再生膜,其特徵在於:該再生膜是以具有生物降解性之高分子聚合物所製成,該再生膜之其中一側為一第一孔隙層,該再生膜的另一側為一第二孔隙層;該第一孔隙層和第二孔隙層均分佈有多數個與外部環境相連通的孔隙,且該第一孔隙層的孔隙尺寸大於該第二孔隙層的孔隙尺寸。 A regenerated film applied to a tissue repairing process, characterized in that the regenerated film is made of a biodegradable polymer, one side of which is a first pore layer, and the regenerated film The other side is a second pore layer; the first pore layer and the second pore layer are each distributed with a plurality of pores communicating with the external environment, and the pore size of the first pore layer is larger than the pore of the second pore layer size. 如申請專利範圍第1項所述應用於組織修復工程之再生膜,其中,該再生膜其中一側之表面為第一表面,該再生膜另一側之表面為第二表面,該第一表面具有該第一孔隙層之孔隙,該第二表面具有該第二孔隙層之孔隙,該第一表面的孔隙尺寸大於該第二表面的孔隙尺寸。 The regenerated film applied to the tissue repair engineering according to the first aspect of the invention, wherein the surface of one side of the regenerated film is a first surface, and the surface of the other side of the regenerated film is a second surface, the first surface An aperture having the first aperture layer, the second surface having an aperture of the second aperture layer, the first surface having a pore size greater than a pore size of the second surface. 一種如申請專利範圍第1項所述應用於組織修復工程之再生膜的製備方法,包括:步驟一,將高分子材料與第一溶劑以預定比例混合配製成高分子溶液;步驟二,將該高分子溶液附著於一模具表面而形成一再生膜半成品;步驟三,以第二溶劑對該再生膜半成品進行隙孔生成加工,於該再生膜半成品之膜壁上形成上述之孔隙。 A method for preparing a regenerated film for use in a tissue repair engineering according to the first aspect of the patent application, comprising: step 1: mixing a polymer material with a first solvent in a predetermined ratio to prepare a polymer solution; and step 2 The polymer solution is attached to a surface of a mold to form a regenerated film semi-finished product; in step 3, the regenerated film semi-finished product is subjected to a pore-forming process by a second solvent, and the pores are formed on the film wall of the regenerated film semi-finished product. 如申請專利範圍第3項所述應用於組織修復工程之再生膜的製備方法,其中,該高分子材料係選自具生物降解性的聚乳酸甘醇酸共聚物(poly(DL-lactci acid-co-glycolic acid,PLGA)、聚己內酯(poly ε-caprolactone,PCL)、聚乳酸(polylactide acid,PLA)之擇一或組合。 The method for preparing a regenerated film for tissue repair engineering according to the third aspect of the invention, wherein the polymer material is selected from the group consisting of biodegradable polylactic acid glycol copolymer (poly(DL-lactci acid- One or a combination of co-glycolic acid (PLGA), polycaprolactone (PCL), and polylactide acid (PLA). 如申請專利範圍第4項所述應用於組織修復工程之再生膜的製備方法,其中,該第一溶劑包含1,4-二氧陸圜(1,4-dioxane)、氯仿 (chloroform)與六氟異丙醇(hexafluoroisopropanol,HFIP)之擇一。 The method for preparing a regenerated film for tissue repair engineering according to the fourth aspect of the invention, wherein the first solvent comprises 1,4-dioxane, chloroform (chloroform) and hexafluoroisopropanol (HFIP). 如申請專利範圍第3項所述應用於組織修復工程之再生膜的製備方法,其中,該第二溶劑為乙醇水溶液。 The method for preparing a regenerated film for use in a tissue repair engineering according to the third aspect of the invention, wherein the second solvent is an aqueous ethanol solution. 如申請專利範圍第6項所述應用於組織修復工程之再生膜的製備方法,其中,該第二溶劑的濃度為10~60%(v/v)。 The method for preparing a regenerated film for use in a tissue repair engineering according to claim 6, wherein the concentration of the second solvent is 10 to 60% (v/v). 如申請專利範圍第6項所述應用於組織修復工程之再生膜的製備方法,其中,該第二溶劑的濃度為20~40%(v/v)。 The method for preparing a regenerated film for use in a tissue repair engineering according to claim 6, wherein the concentration of the second solvent is 20 to 40% (v/v). 如申請專利範圍第3項所述應用於組織修復工程之再生膜的製備方法,其中,該再生膜半成品膜壁外層的孔隙大小係藉由步驟三中的第二溶劑的極性大小來調節。 The method for preparing a regenerated film for tissue repair engineering according to claim 3, wherein the pore size of the outer layer of the regenerated film semi-finished film is adjusted by the polarity of the second solvent in the third step. 如申請專利範圍第3項所述應用於組織修復工程之再生膜的製備方法,其中,執行步驟二之前,先在模具的表面預塗佈一層阻斷第二溶劑侵入高分子材料與模具之間的親水性凝膠層。 The method for preparing a regenerated film for use in a tissue repairing process as described in claim 3, wherein, before performing step two, a surface of the mold is precoated with a layer of a second solvent to invade the polymer material and the mold. Hydrophilic gel layer.
TW99125493A 2010-07-30 2010-07-30 And a method for producing the regenerated film and the method for producing the regenerated film TWI424861B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW99125493A TWI424861B (en) 2010-07-30 2010-07-30 And a method for producing the regenerated film and the method for producing the regenerated film

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW99125493A TWI424861B (en) 2010-07-30 2010-07-30 And a method for producing the regenerated film and the method for producing the regenerated film

Publications (2)

Publication Number Publication Date
TW201204418A TW201204418A (en) 2012-02-01
TWI424861B true TWI424861B (en) 2014-02-01

Family

ID=46761248

Family Applications (1)

Application Number Title Priority Date Filing Date
TW99125493A TWI424861B (en) 2010-07-30 2010-07-30 And a method for producing the regenerated film and the method for producing the regenerated film

Country Status (1)

Country Link
TW (1) TWI424861B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101474430A (en) * 2009-01-13 2009-07-08 武汉大学 Tissue regeneration membrane with bioactivity and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101474430A (en) * 2009-01-13 2009-07-08 武汉大学 Tissue regeneration membrane with bioactivity and preparation method thereof

Also Published As

Publication number Publication date
TW201204418A (en) 2012-02-01

Similar Documents

Publication Publication Date Title
Chen et al. New forms of electrospun nanofiber materials for biomedical applications
US11946164B2 (en) Nanofiber structures and methods of use thereof
CN112553785B (en) Double-layer guided tissue regeneration membrane and preparation method thereof
US20210008505A1 (en) Novel electrospun synthetic dental barrier membranes for guided tissue regeneration and guided bone regeneration applications
TWI539977B (en) Contains non-woven material for bone filling
US20250375553A1 (en) Tissue derived porous matrices and methods for making and using same
US9771410B2 (en) Foam-formed collagen strand
US8460691B2 (en) Fenestrated wound repair scaffold
WO2010081408A1 (en) Bioactive tissue regeneration film and preparation method thereof
EP2590694A2 (en) Bone regeneration membrane and method for forming a bone regeneration membrane
KR101293209B1 (en) structure for guided tissue regeneration
EP3043833B1 (en) Tubular porous foam scaffolds with gradient pores for tissue engineering
CN108837184A (en) A kind of composite membrane and preparation method thereof for Guided Bone Regeneration
WO2024025978A2 (en) Novel electrospun synthetic membranes for soft tissue repair applications
JP3389316B2 (en) Absorbable biomaterial and method for producing the same
TWI424861B (en) And a method for producing the regenerated film and the method for producing the regenerated film
Kamaci et al. A Review polylactic acid and gelatin biomaterial GBR (Guided Bone Regeneration) and multilayer GBR membranes
CN115006597A (en) Oral cavity repairing film and preparation method thereof
CN106535950A (en) Dental regenerative membrane using cocoon and its manufacturing method
CN1210071C (en) Biological active bone tissue inducing regeneration film and preparation method
KR101601674B1 (en) Surface Modified Nanofibrous GBR membrane and preparation method thereof
Noritake et al. Use of a gelatin hydrogel membrane containing β-tricalcium phosphate for guided bone regeneration enhances rapid bone formation
WO2012029971A1 (en) Compound material of fibrin glue and fiber molding
CN114470324A (en) A new strategy for general bone implant modification for the intervention of diabetic bone defects
US20250345481A1 (en) Nanocomposite hydrogels and related methods and applications

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees